BLUE JET HEALTHCARE LTD
BLUEJET · General/Diversified · NSE
₹470
Current Market Price
Fair Value (DCF)
₹202
Discount to FV
-57.1%
Updated just now
YieldIQ Score
30/100
Piotroski F-Score
4/9
Economic Moat
Moderate
Confidence
43%
ROE
18.2%
Debt/Equity
0.03
WACC
11.1%
Market Cap
₹8,149 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
25.9%
Return on capital employed
EV / EBITDA
20.8×
Enterprise multiple
Debt / EBITDA
0.1×
Leverage vs earnings
Interest Coverage
4061.9×
EBIT covers interest
Current Ratio
3.93×
Short-term liquidity
Asset Turnover
0.67×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.6%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹469.75
Bear case
Discount -283.1%
Base case
Discount -132.9%
Bull case
Discount -85.3%
Ratio Trends
BLUEJET · last 5 annual periods
ROE
18.2%
ROCE
25.9%
Operating Margin
—
Debt / Equity
0.03×
PE
—
EV / EBITDA
—
Historical Financials
BLUEJET · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 yfinance | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹678 Cr | ₹721 Cr | ₹710 Cr | ₹1030 Cr | ₹947 Cr | +8.7% |
| EBITDA | ₹268 Cr | ₹243 Cr | ₹248 Cr | ₹424 Cr | ₹363 Cr | +7.8% |
| EBIT | — | — | ₹220 Cr | — | — | +0.0% |
| PAT | ₹182 Cr | ₹160 Cr | ₹164 Cr | ₹305 Cr | ₹248 Cr | +8.1% |
| EPS (diluted) | — | — | ₹9.44 | — | — | +0.0% |
| CFO | ₹146 Cr | ₹142 Cr | ₹241 Cr | ₹45.8 Cr | ₹334 Cr | +22.9% |
| CapEx | ₹-22.9 Cr | ₹-59.3 Cr | ₹-174 Cr | ₹-79.9 Cr | ₹-219 Cr | — |
| FCF | ₹123 Cr | ₹82.3 Cr | ₹67.0 Cr | ₹-34.1 Cr | ₹115 Cr | -1.8% |
| Total Assets | ₹713 Cr | ₹862 Cr | ₹1059 Cr | ₹1418 Cr | ₹1641 Cr | +23.2% |
| Total Debt | ₹17.3 Cr | ₹3.4 Cr | ₹1.6 Cr | ₹20.0 Cr | ₹42.2 Cr | +24.9% |
| Shareholders' Equity | ₹522 Cr | ₹681 Cr | ₹845 Cr | ₹1133 Cr | ₹1360 Cr | +27.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
BLUEJET vs 2 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
SUPRIYA SUPRIYA | — | — | Pending | 18.9% | — |
 CONCORDBIO CONCORDBIO | — | — | Pending | 20.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
2 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹2.20/sh
Last payout
2025-09-19
₹1.20
Peak payout
₹1.20
Trailing yield
0.26%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. BLUE JET HEALTHCARE LTD (BLUEJET.NS) trades at 469.75 vs a model fair value of 201.71, a gap of -57.1%. Piotroski F-score: 4/9. Moat labe...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of BLUEJET →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for BLUEJET →
Compare
Head-to-head with peers
Compare BLUEJET side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse BLUEJETNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.